Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2013 1
2014 3
2015 6
2016 6
2017 4
2018 2
2019 8
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
Ueland T, Åkerblom A, Ghukasyan T, Michelsen AE, Becker RC, Bertilsson M, Budaj A, Cornel JH, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Wallentin L; PLATO Investigators. Ueland T, et al. Atherosclerosis. 2020 Jan;293:35-41. doi: 10.1016/j.atherosclerosis.2019.11.031. Epub 2019 Nov 29. Atherosclerosis. 2020. PMID: 31835039 Clinical Trial.
Interleukin-18 in patients with acute coronary syndromes.
Åkerblom A, James SK, Lakic TG, Becker RC, Cannon CP, Steg PG, Himmelmann A, Katus HA, Storey RF, Wallentin L, Weaver WD, Siegbahn A; PLATO Investigators. Åkerblom A, et al. Clin Cardiol. 2019 Dec;42(12):1202-1209. doi: 10.1002/clc.23274. Epub 2019 Oct 9. Clin Cardiol. 2019. PMID: 31596518 Free PMC article. Clinical Trial.
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Åkerblom A, Wojdyla D, Steg PG, Wallentin L, James SK, Budaj A, Katus HA, Himmelmann A, Huber K, Siegbahn A, Storey RF, Becker RC; PLATO Investigators. Åkerblom A, et al. J Thromb Thrombolysis. 2019 Nov;48(4):563-569. doi: 10.1007/s11239-019-01938-2. J Thromb Thrombolysis. 2019. PMID: 31512201 Free PMC article. Clinical Trial.
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Åkerblom A, Wojdyla DM, Wallentin L, James SK, de Souza Brito F, Steg PG, Cannon CP, Katus HA, Himmelmann A, Storey RF, Becker RC, Lopes RD; PLATO Investigators. Åkerblom A, et al. Am Heart J. 2019 Jul;213:57-65. doi: 10.1016/j.ahj.2019.04.006. Epub 2019 Apr 18. Am Heart J. 2019. PMID: 31108273 Clinical Trial.
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.
Kontny F, Andersen T, Ueland T, Åkerblom A, Lakic TG, Michelsen AE, Aukrust P, Bertilsson M, Becker RC, Himmelmann A, James SK, Siegbahn A, Storey RF, Wallentin L; PLATO Investigators. Kontny F, et al. Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):313-322. doi: 10.1177/2048872619846334. Epub 2019 Apr 24. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 31017470 Clinical Trial.
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.
Franchi F, James SK, Ghukasyan Lakic T, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Storey RF, Himmelmann A, Wallentin L, Angiolillo DJ; PLATO Investigators. Franchi F, et al. J Am Heart Assoc. 2019 Mar 19;8(6):e011139. doi: 10.1161/JAHA.118.011139. J Am Heart Assoc. 2019. PMID: 30857464 Free PMC article. Clinical Trial.
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes.
Ueland T, Åkerblom A, Ghukasyan T, Michelsen AE, Becker RC, Bertilsson M, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Wallentin L; PLATO Investigators. Ueland T, et al. Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):294-302. doi: 10.1161/ATVBAHA.118.311042. Arterioscler Thromb Vasc Biol. 2019. PMID: 30580572 Free article. Clinical Trial.
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study.
Storey RF, Ardissino D, Vignali L, Cairns R, Becker RC, Cannon CP, Mahaffey KW, Himmelmann A, Katus HA, James SK, Wallentin L; PLATO Investigators. Storey RF, et al. Thromb Haemost. 2018 Feb;118(2):427-429. doi: 10.1160/TH17-05-0355. Epub 2018 Jan 29. Thromb Haemost. 2018. PMID: 29443375 Clinical Trial. No abstract available.
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.
Lowenstern A, Storey RF, Neely M, Sun JL, Angiolillo DJ, Cannon CP, Himmelmann A, Huber K, James SK, Katus HA, Morais J, Siegbahn A, Steg PG, Wallentin L, Becker RC; PLATO Investigators. Lowenstern A, et al. J Thromb Thrombolysis. 2017 Aug;44(2):145-153. doi: 10.1007/s11239-017-1516-y. J Thromb Thrombolysis. 2017. PMID: 28608165 Free PMC article. Clinical Trial.
30 results